COLLEGIUM PHARMACEUTICAL, INC (COLL)
Since Aug 13, 2015, COLLEGIUM PHARMACEUTICAL, INC (COLL) has reported earnings 44 times. On average the shares move ±7.84% post-earnings, with a positive reaction 63.6% of the time. Its largest post-earnings gain was +31.39% (Nov 06, 2019) and its largest decline was -17.31% (Aug 05, 2021). The next earnings report is predicted for 2026-08-07 (approximate).
Earnings reactions
How COLL moved on each past earnings report.
Earnings Impact
Total Earnings
44
Avg Abs. Movement
±7.84%
Positive %
63.6%
Negative %
36.4%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| May 07, 2026 | ☀ PRE | +7.67% | open_in_new |
| Feb 26, 2026 | ☀ PRE | -3.34% | open_in_new |
| Nov 06, 2025 | ☀ PRE | +13.42% | open_in_new |
| Aug 07, 2025 | ☀ PRE | +10.72% | open_in_new |
Earnings Count
44
Total earnings in dataset
Avg Abs. Movement
±7.84%
Avg % price change on earnings
Institutional ownership
Holdings as of Mar 31, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 144 | 20260717 | open_in_new SEC.gov |
| 144 | 20260715 | open_in_new SEC.gov |
| 8-K/A | 20260630 | open_in_new SEC.gov |
| 4 | 20260610 | open_in_new SEC.gov |
| S-8 | 20260601 | open_in_new SEC.gov |
| S-8 | 20260601 | open_in_new SEC.gov |
| 4 | 20260520 | open_in_new SEC.gov |
| 144 | 20260518 | open_in_new SEC.gov |
| 3 | 20260518 | open_in_new SEC.gov |
| 4 | 20260518 | open_in_new SEC.gov |
Frequently asked about COLL earnings
When does COLLEGIUM PHARMACEUTICAL, INC report earnings next? expand_more
COLLEGIUM PHARMACEUTICAL, INC (COLL)'s next earnings date is approximate for 2026-08-07. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does COLL stock move after earnings? expand_more
Over 44 reports, COLL has moved an average of ±7.84% the session after earnings, closing higher 63.6% of the time.
What was COLL's biggest post-earnings move? expand_more
COLL's largest post-earnings gain on record was +31.39% on Nov 06, 2019, and its largest decline was -17.31% on Aug 05, 2021.
Where can I find COLLEGIUM PHARMACEUTICAL, INC's SEC filings? expand_more
All of COLLEGIUM PHARMACEUTICAL, INC's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right
Reporting around the same time
- ALAMO GROUP INC (ALG) earnings 2026-08-04
- Aligos Therapeutics, Inc. Common Stock (ALGS) earnings 2026-08-05
- AbCellera Biologics Inc. Common Shares (ABCL) earnings 2026-08-05
- Airbnb (ABNB) earnings 2026-08-05
- Arcosa, Inc. (ACA) earnings 2026-08-04
- ACADIA PHARMACEUTICALS INC (ACAD) earnings 2026-08-05
- ACCO BRANDS Corp (ACCO) earnings 2026-08-04
- ProFrac Holding Corp. (ACDC) earnings 2026-08-07